GlassScriptPhysician profile
Charles F Gebhardt
NPI 1407842859
$15,639.36
in general payments reported to CMS, 2019-2025
53 companies · $2,324 in 2025
The $2,324 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,466 · 2020: $2,083 · 2021: $2,109 · 2022: $2,201 · 2023: $2,239 · 2024: $2,217 · 2025: $2,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,779 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,778.72 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,847.90 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,383.69 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,097.98 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $960.60 | 2019-2025 | |
| Lilly USA, LLC | $877.38 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $787.04 | 2022-2025 | |
| Amgen INC. | $683.39 | 2019-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $622.71 | 2021-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $608.54 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $604.40 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $570.81 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Neurocrine Biosciences, INC. | $477.00 | 2023-2025 | Ingrezza, Ongentys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $455.52 | 2019-2023 | Ofev, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $424.42 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $419.34 | 2019-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $386.72 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $381.27 | 2019-2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $238.59 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $233.76 | 2019-2023 | Trintellix |
| Esperion Therapeutics, INC. | $188.34 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $176.42 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $174.97 | 2023-2025 | Gemtesa |
| Ironwood Pharmaceuticals, INC | $174.34 | 2020-2023 | Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.65 | 2019-2025 | Xifaxan |
| Corcept Therapeutics | $161.75 | 2024-2025 | Korlym |
| Abbott Laboratories | $154.78 | 2021-2024 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $139.09 | 2024-2025 | Rexulti |
| Eisai INC. | $117.48 | 2020-2025 | |
| Shield Therapeutics INC | $113.82 | 2023-2025 | Accrufer |
| Biogen, INC. | $89.80 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $82.06 | 2022 | |
| Daiichi Sankyo INC. | $79.45 | 2022-2023 | Injectafer |
| Amarin Pharma, INC. | $62.20 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $59.87 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $53.45 | 2024-2025 | Voquezna |
| Kvk-Tech, INC. | $50.56 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $48.31 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $45.87 | 2019 | |
| Arbor Pharmaceuticals, INC. | $39.94 | 2020-2021 | |
| Ucb, INC. | $38.29 | 2024 | Nayzilam |
| Supernus Pharmaceuticals, INC. | $38.06 | 2019 | |
| Ardelyx, INC. | $36.49 | 2025 | Ibsrela |
| Biohaven Pharmaceuticals, INC. | $36.27 | 2021 | |
| Organogenesis INC. | $35.81 | 2022-2025 | Puraply Wound Matrix |
| Nevro Corp. | $34.71 | 2021 | |
| Corium, LLC | $33.25 | 2023 | Adlarity |
| Sanofi Pasteur INC. | $28.68 | 2019-2021 | |
| Genentech USA, INC. | $26.58 | 2019-2025 | Ocrevus Zunovo |
| Exact Sciences Corporation | $19.36 | 2024 | Cologuard Collection Kit |
| Seqirus USA INC | $18.90 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Teleflex LLC | $18.12 | 2024 | Urolift |
| Almatica Pharma LLC | $14.63 | 2021 | |
| Scilex Pharmaceuticals INC. | $13.00 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Gebhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.